<VariationArchive VariationID="840533" VariationName="NM_001172509.2(SATB2):c.2002_2021del (p.Tyr668fs)" VariationType="Deletion" Accession="VCV000840533" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="825541" VariationID="840533">
      <GeneList>
        <Gene Symbol="LOC126806462" FullName="MED14-independent group 3 enhancer GRCh37_chr2:200136608-200137807" GeneID="126806462" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199271885" stop="199273084" display_start="199271885" display_stop="199273084" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SATB2" FullName="SATB homeobox 2" GeneID="23314" HGNC_ID="HGNC:21637" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199269500" stop="199471266" display_start="199269500" display_stop="199471266" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200134222" stop="200335988" display_start="200134222" display_stop="200335988" Strand="-" />
          </Location>
          <OMIM>608148</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001172509.2(SATB2):c.2002_2021del (p.Tyr668fs)</Name>
      <CanonicalSPDI>NC_000002.12:199272391:CCGTGGTGCTTCACGTGGTACCG:CCG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199272392" stop="199272411" display_start="199272392" display_stop="199272411" variantLength="20" positionVCF="199272391" referenceAlleleVCF="CCCGTGGTGCTTCACGTGGTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200137115" stop="200137134" display_start="200137115" display_stop="200137134" variantLength="20" positionVCF="200137114" referenceAlleleVCF="CCCGTGGTGCTTCACGTGGTA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Y668fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.200137118_200137137del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.200137118_200137137del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.199272395_199272414del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.199272395_199272414del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016976.2" sequenceAccession="NG_016976" sequenceVersion="2" change="g.203856_203875del">
            <Expression>NG_016976.2:g.203856_203875del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172509.2" sequenceAccession="NM_001172509" sequenceVersion="2" change="c.2002_2021del" MANESelect="true">
            <Expression>NM_001172509.2:c.2002_2021del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165980.1" sequenceAccession="NP_001165980" sequenceVersion="1" change="p.Tyr668fs">
            <Expression>NP_001165980.1:p.Tyr668fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172517.1" sequenceAccession="NM_001172517" sequenceVersion="1" change="c.2002_2021del">
            <Expression>NM_001172517.1:c.2002_2021del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165988.1" sequenceAccession="NP_001165988" sequenceVersion="1" change="p.Tyr668fs">
            <Expression>NP_001165988.1:p.Tyr668fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015265.4" sequenceAccession="NM_015265" sequenceVersion="4" change="c.2002_2021del">
            <Expression>NM_015265.4:c.2002_2021del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056080.1" sequenceAccession="NP_056080" sequenceVersion="1" change="p.Tyr668fs">
            <Expression>NP_056080.1:p.Tyr668fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1692186575" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001172509.2(SATB2):c.2002_2021del (p.Tyr668fs) AND Chromosome 2q32-q33 deletion syndrome" Accession="RCV001042546" Version="8">
        <ClassifiedConditionList TraitSetID="10106">
          <ClassifiedCondition DB="MedGen" ID="C2676739">Chromosome 2q32-q33 deletion syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="10106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1446" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chromosome 2q32-q33 deletion syndrome</ElementValue>
                <XRef ID="MONDO:0012864" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glass syndrome</ElementValue>
                <XRef Type="Allelic variant" ID="608148.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608148.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608148.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">2q33.1 deletion syndrome</ElementValue>
                <XRef ID="51" DB="Decipher" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GLASS</ElementValue>
                <XRef Type="MIM" ID="612313" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13206" />
                <XRef ID="13206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SATB2-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited to absent speech, behavioral issues, and craniofacial anomalies. All individuals described to date have manifest developmental delay / intellectual disability, with severe speech delay. Affected individuals often have hypotonia and feeding difficulties in infancy. Behavioral issues may include autistic features, hyperactivity, and aggressiveness. Craniofacial anomalies may include palatal abnormalities (cleft palate, high-arched palate, and bifid uvula), micrognathia, and abnormal shape or size of the upper central incisors. Less common features include skeletal anomalies (osteopenia, pectus deformities, kyphosis/lordosis, and scoliosis), growth restriction, strabismus/refractive errors, congenital heart defects, genitourinary anomalies, and epilepsy. While dysmorphic features have been described in individuals with this condition, these features are not typically distinctive enough to allow for a clinical diagnosis of SAS.</Attribute>
                <XRef ID="NBK458647" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="Decipher">
                <URL>https://decipher.sanger.ac.uk/syndrome/51</URL>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29023086</ID>
                <ID Source="BookShelf">NBK458647</ID>
              </Citation>
              <XRef ID="251019" DB="Orphanet" />
              <XRef ID="C2676739" DB="MedGen" />
              <XRef ID="MONDO:0012864" DB="MONDO" />
              <XRef Type="MIM" ID="612313" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2371475" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6274602|MedGen:C2676739" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001206231" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change results in a premature translational stop signal in the SATB2 gene (p.Tyr668Glufs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acids of the SATB2 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the SATB2 protein. Other variant(s) that disrupt this region (p.Glu692*) have been determined to be pathogenic (PMID:¬†28151491). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with SATB2-related conditions. ClinVar contains an entry for this variant (Variation ID: 840533). This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SATB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.200137115_200137134del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2676739" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2371475" TraitType="Disease" MappingType="XRef" MappingValue="C2676739" MappingRef="MedGen">
        <MedGen CUI="C2676739" Name="Chromosome 2q32-q33 deletion syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

